marktaratkin Profile Banner
Mark Taratkin Profile
Mark Taratkin

@marktaratkin

Followers
422
Following
2K
Media
60
Statuses
315

MD, Urologist and Researcher, Institute for Urology and Reproductive Health, @SechenovUni. Associate member of #ESUI and @EAUYAUrology

Moscow, Russia
Joined September 2012
Don't wanna be here? Send us removal request.
@uroAI_news
UroAI News
4 months
Artificial Intelligence Generates Multilingual Cancer Patient Materials with Superior Readability and Equivalent Accuracy, Clarity, and Completeness to Expert-Written Texts https://t.co/kO4iZWyFD2
Tweet card summary image
uroai.org
Read about Artificial Intelligence Generates Multilingual Cancer Patient Materials with Superior Readability and Equivalent Accuracy, Clarity, and Completeness to Expert-Written Texts at UroAI.
2
10
12
@Cacciamani_MD
Dr. Giovanni E Cacciamani MD MSc FEBU ๐Ÿ‡ฎ๐Ÿ‡น๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ช๐Ÿ‡บ
6 months
๐Ÿง  Can AI Improve Patient Education? Our new study finds that GPT-4 can craft easy-to-read patient education materials that adhere to cancer guidelines with high accuracy and clarity ๐Ÿ“š Improved Readability - GPT-4 PEMs scored better (FKRE: 70.8) than originals (FKRE: 43.5)
1
15
37
@AndreyOMorozov
Andrey Morozov
1 year
Great opportunity to attend 13th Conference of #EUS and present our experience with the novel MG needle at the plenary session. @MagomedGazimiev
0
1
3
@Cacciamani_MD
Dr. Giovanni E Cacciamani MD MSc FEBU ๐Ÿ‡ฎ๐Ÿ‡น๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ช๐Ÿ‡บ
8 months
Canโ€™t wait to geek out on #ArtificialIntelligence and #DigitalHealth at #AUA25! ๐Ÿค–๐Ÿ’ฅ Proud to team up with my fellow urologists to share some ๐Ÿ”ฅ content for our awesome urology fam. Letโ€™s bring the future to the OR! ๐Ÿ’ฌ๐Ÿ’™ #UroSquad #FutureIsNow @NakadaSteve @GabyGonzalezMD
@AmerUrological
Amer. Urol. Assn.
8 months
๐ŸŽ‰ The #AUA25 Who to Follow list is here! ๐ŸŽ‰ These experts will be at the Annual Meeting in Las Vegas, sharing their experience with live updates, informative videos, and more. Stay connected by following them on X (formerly Twitter). ๐Ÿ“ฒ But thatโ€™s not allโ€”stay tuned! ๐Ÿšจ Weโ€™ll
3
10
32
@Cacciamani_MD
Dr. Giovanni E Cacciamani MD MSc FEBU ๐Ÿ‡ฎ๐Ÿ‡น๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ช๐Ÿ‡บ
2 years
@elietoubiana @CanesDavid the AGI's ability is indeed impressive, but it is limited to physician knowledge more than the "physician ability" as reported in the graph. Therefore, the medical singularity is not even close to being reached Those of us who practice #MEDICINE understand the importance of the
1
11
10
@Sevans_axelsson
Susan Evans Axelsson
2 years
@ProstatePioneer
Prostate PIONEER
2 years
๐Ÿ“ข We are proud to announce our latest article in press: Clinical Characterization of Patients Diagnosed with #ProstateCancer and Undergoing Conservative Management: a #ProstatePIONEER Analysis Based on #BigData, published in @Euplatinum; https://t.co/cnlfTrRmvA
0
2
12
@marktaratkin
Mark Taratkin
2 years
COVID-19 has changed the landscape of digital education. However, will it return to pre-COVID-19 times eventually? ๐Ÿค” @JGomezRivas and @EAU_YAUroTech have looked into it!
0
0
0
@UrowebESU
European School of Urology (EAU ESU)
2 years
Experts @Cacciamani_MD @AliSerdarGozen @kahmed198 @pidebacker & @NicholasRaison will dive into current AI applications, possibilities & ethical considerations in urology. Join us in the new #UROwebinar next week! Register for free + get CME credit ๐Ÿ‘‡ https://t.co/Tthr0sc2Yg
0
20
53
@marktaratkin
Mark Taratkin
3 years
AI is on the riseโ—๏ธ @EAU_YAUroTech meta-analysis of AI in PCa pathology results: 1-accuracy โฌ†๏ธ 98% 2-expert level grading โœ… 3-numerous possible applications https://t.co/pFYaeuAh6R ๐Ÿ‘๐Ÿปto our experts team! @AndreyOMorozov @Cacciamani_MD @Dmitry_Enikeev @JGomezRivas
0
10
26
@Dmitry_Enikeev
Dmitry Enikeev
3 years
Our recent review on different lasers in management of UTUC in Cancers https://t.co/00gTaHuYIz. Thanks to @lusuardi_lukas for kind invitation.
0
5
19
@marktaratkin
Mark Taratkin
3 years
๐Ÿšจ Calling all #urology friends ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ‘จโ€โš•๏ธ! Join us in assessing #ChatGPT's impact on academic ๐ŸŽ“ and clinical settings ๐Ÿฉบ ๐Ÿ’กWant to stay updated on @uroGPT initiatives? Share your contact at the survey's end! ๐Ÿ”— Fill out the survey now:
0
0
0
@Cacciamani_MD
Dr. Giovanni E Cacciamani MD MSc FEBU ๐Ÿ‡ฎ๐Ÿ‡น๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ช๐Ÿ‡บ
3 years
๐Ÿคฏ Just playing around with the new @MetaAI release - the Segment Anything Model (SAM). Automated Prostate Segmentation โœ… The future is NOW! @Urology_AI @USC_Urology @ALDCAbreu @EAU_YAUroTech @Uroweb @VPanebiancoIT @giga_fra @USCRadiomics @USC_Urology #MedTwitter
1
19
116
@Cacciamani_MD
Dr. Giovanni E Cacciamani MD MSc FEBU ๐Ÿ‡ฎ๐Ÿ‡น๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ช๐Ÿ‡บ
3 years
Thrilled to share a new initiative @uroGPT ๐Ÿง‘โ€๐Ÿ’ป๐Ÿ‘ฉโ€๐Ÿ”ฌ๐Ÿ‘จโ€โš•๏ธThe @uroGPT HUB is a research collective that aims to improve the understanding of #GPT and #LLMs in #Urology 7 projects already ongoing 1 global survey 1 guideline development @USC_Urology @Urology_AI Join @uroGPT for more
37
37
201
@UrologyUni
Urology Research Group, Sechenov University
3 years
So glad to restart or weekly Journal Club meetings ๐Ÿ“ฐ๐Ÿ”ฌโœ…there is aways something to discuss ๐Ÿ“ฃ
1
2
2
@EurUrolFocus
Eur Urol Focus
3 years
Current Issue: Does Endoscopic Enucleation of the Prostate Need New Lasers? Current Perspective on New Laser Devices https://t.co/24G6X2flXt @marktaratkin @Dmitry_Enikeev #prostate #laserdevices #urology #MedTwitter
0
4
9
@EAU_YAUroTech
EAU Young Academics Urologist. Uro-Tech group
4 years
We welcome @rodlerseverin into our @EAU_YAUroTech group Severin is our expert in #telemedicine and Digital Therapeutics ๐Ÿ‘๐Ÿ‘๐Ÿ‘
0
7
14
@Dmitry_Enikeev
Dmitry Enikeev
4 years
Do we need new energy sources for #AEEP? ๐Ÿง Discussed current perspectives in @EurUrolFocus. ๐Ÿ‘‰ https://t.co/Isfa75d8OV
3
20
67
@Cacciamani_MD
Dr. Giovanni E Cacciamani MD MSc FEBU ๐Ÿ‡ฎ๐Ÿ‡น๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ช๐Ÿ‡บ
4 years
๐Ÿ’ก#AugmentedReality has been increasingly used in myriad surgical specialties including Urology ๐Ÿ“š37 studies included โœ…Advances in AR have led to increased ability to identify anatomic landmarks and improve outcomes @EAU_YAUroTech ๐Ÿ‘‰ https://t.co/TABGVJRz21
1
15
47
@UrologyUni
Urology Research Group, Sechenov University
4 years
Placebo effect improves symptoms of chronic prostatitis ๐Ÿ’Š Yet to what extent ๐Ÿค” ? Our lastest review has the answer - questionnaires are affected, and instrumental tests are not @AndreyOMorozov @DiBabaevskaya @AK_Bazarkin @Dmitry_Enikeev https://t.co/WwITz54ajq
0
4
9
@JGomezRivas
Juan Gรณmez Rivas
4 years
๐Ÿ†• RARC learning curve length varies from 10-50 cases. The > common criteria for evaluating include opโฑ & lymph node yield. Blood loss, length of ๐Ÿฅ stay & complications may be harder to use systematically as a means of learning curve assessment https://t.co/eSoZ860QKb
0
14
58